Cargando…
The Impact of Methylenetetrahydrofolate Reductase C677T Polymorphism on Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation with Methotrexate Prophylaxis
Pharmacogenomics can explain the inter-individual differences in response to drugs, including methotrexate (MTX) used for acute graft-versus-host disease (aGVHD) prophylaxis during hematopoietic stem cell transplantation (HSCT). In real-world practice, preplanned MTX dose is arbitrarily modified acc...
Autores principales: | Byun, Ja Min, Kim, Hea-Lim, Shin, Dong-Yeop, Koh, Youngil, Yoon, Sung-Soo, Seong, Moon-Woo, Park, Sung Sup, Kim, Jin Hee, Lee, Yun-Gyoo, Kim, Inho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5081210/ https://www.ncbi.nlm.nih.gov/pubmed/27783703 http://dx.doi.org/10.1371/journal.pone.0163998 |
Ejemplares similares
-
Association between preconditioning absolute lymphocyte count and transplant outcomes in patients undergoing matched unrelated donor allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning and anti-thymocyte globulin
por: Seo, Jeongmin, et al.
Publicado: (2021) -
Should patients receive consolidation chemotherapy before reduced
intensity allogeneic hematopoietic stem cell transplantation for acute myeloid
leukemia in first complete remission?
por: Byun, Ja Min, et al.
Publicado: (2021) -
Methylenetetrahydrofolate reductase C677T polymorphism in patients with lung cancer in a Korean population
por: Cui, Lian-Hua, et al.
Publicado: (2011) -
Allogeneic Stem Cell Transplantation in Relapsed/Refractory Multiple Myeloma Treatment: Is It Still Relevant?
por: Park, Hyunkyung, et al.
Publicado: (2020) -
Prevalence of methylenetetrahydrofolate reductase C677T polymorphism in eastern Uttar Pradesh
por: Rai, Vandana, et al.
Publicado: (2012)